Last reviewed · How we verify
Piritramid
At a glance
| Generic name | Piritramid |
|---|---|
| Also known as | Dipidolor |
| Sponsor | The Institute of Molecular and Translational Medicine, Czech Republic |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Influence of Opioid Analgesia on Circulating Tumor Cells in Laparoscopic Colorectal Cancer Surgery (PHASE4)
- Influence of Opioid Analgesia on Circulating Tumor Cells in Open Colorectal Cancer Surgery (PHASE4)
- Monitoring Pupillary Reflex Dilatation for Optimized Postoperative Opioid Delivery Before Extubation. (NA)
- Effectivness of Tramadol or Topic Lidocaine on Postoperative Analgesia in Laparoscopic Colorectal Resection. (NA)
- Serratus Anterior Plane Block Versus Standard of Care After Totally Endoscopic Aortic Valve Replacement (NA)
- Influence of Hypnoacupuncture on Early Perioperative Recovery (NA)
- Effect of VR on Anxiety and Pain in Gynecological Surgery (NA)
- Postoperative Analgesia With a Catheter Under the Erector Spinae Muscle for Videothoracoscopic Lung Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Piritramid CI brief — competitive landscape report
- Piritramid updates RSS · CI watch RSS
- The Institute of Molecular and Translational Medicine, Czech Republic portfolio CI